原发性免疫性血小板减少症的治疗进展(1)
摘 要 原发性免疫性血小板减少症是一种免疫介导的获得性血小板减少所致出血性疾病,其患者外周血小板计数<100×109/L,但没有引起血小板减少的明显诱因或基础疾病。近年来,随着对此疾病发病机制的认识逐渐深入,在其治疗方面也有了很多新的进展。关键词 原发性免疫性血小板减少症 血小板减少症 治疗
中图分类号:R554.6; R973 文献标识码:A 文章编号:1006-1533(2014)11-0015-04
Advances in the treatment of primary immune thrombocytopenia*
Wang Weiguang, Cheng Yunfeng**
(Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai 200032, China)
ABSTRACT Primary immune thrombocytopenia (ITP) is an immune-mediated acquired bleeding disorder characterized by isolated thrombocytopenia due to increased platelet clearance and/or impaired thrombocytogenesis ......
您现在查看是摘要页,全文长 3796 字符。